Published

A cross-national comparison of nonmedical and medical use of psychedelic drugs in the international cannabis policy study.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: The International journal on drug policy
Date: 2026-08-01
Source: PubMed
DOI: 10.1016/j.drugpo.2026.105348
PubMed: 42247761

Authors

Graham M Ge Y Pacula RL Pessar SC Wilkins C Hall W Hammond D

Watch author

Derived topics and classifications

psilocybin Mechanism of Action Clinical Trial Observational Study Adverse Events Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

A cross-national comparison of nonmedical and medical use of psychedelic drugs in the international cannabis policy study.2026-08-01

Related papers

Policy Considerations for Psychedelics in Research and Medicine - What’s Next on the Schedule?Journal of Science Policy & Governance · 2026-07-02 The Psychedelic Social Club: a regulatory concept for people who use psychedelics?Drugs Education Prevention and Policy · 2023-10-30 Case report: Prolonged amelioration of mild red-green color vision deficiency following psilocybin mushroom useDrug Science Policy and Law · 2023-01-01 Reported effects of psychedelic use on those with low well-being given various emotional states and social contextsDrug Science Policy and Law · 2020-01-01 Balancing safety and access in Oregon’s psilocybin servicesInternational Journal of Drug Policy · 2026-09-01 Regulatory ambiguity and governance challenges for psilocybin mushrooms in BrazilInternational Journal of Drug Policy · 2026-04-01 The impact of drug control on wider research: Psychedelic mushroom explorationDrug Science Policy and Law · 2026-01-01 A lexicon for psychedelic research and treatmentDrug Science Policy and Law · 2025-08-31